It needs to start moving away from collaborations, partnerships and beta testing, free trials into making money. I think they have done a great job in reducing costs. Looks like the grants/R&D rebates have not eventuated. Ludomade? Any sale price on this? The most recent Business update half explained they could no longer justify expenses in the US, why they kept the staff on when they no longer pursuing the UGC product. Now they announce a revenue share agreement with a UK based Social Media firm (so what the social science does)? Hopefully this is not another Pivot for MG to jump ship. But if it was still Noah running it he would have acquired huumun for some ridiculously overpriced amount.
February 2020 was meant to be the full market launch of Opyl ?? (Investor Presentation 30 Oct 2019) (But then again the MediaConsent of old now shelved was always just around the corner)
I am hoping I am wrong and this can start to climb back up, but I think the price movement in the teens might be over (the cap raise was @0.001 or 0.10 so those involved could have made some $ until now.
